BSE

HCP PLASTENE BULKPACK LIMITED (HPBL.BO)

318.00 ▼ -2.48% as of 6 Oct, 07:59

Stocky turns companies like HCP PLASTENE BULKPACK LIMITED into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
C++
Weak — heavy debt or patchy profits.

How safely HCP PLASTENE BULKPACK LIMITED is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for HCP PLASTENE BULKPACK LIMITED:

—
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see a Verdict/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

—
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

—
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

HCP PLASTENE BULKPACK LIMITED (HPBL.BO) — frequently asked

Is HCP PLASTENE BULKPACK LIMITED (HPBL.BO) a good investment right now?

HCP PLASTENE BULKPACK LIMITED is under analysis by Stocky. Once the full Verdict is calculated, this page updates automatically with a 0–100 score, band (Buy / Hold / Avoid), and the specific thesis.

What is HPBL.BO's Stocky Verdict?

The Stocky Verdict for HPBL.BO is being computed. It's a 0–100 composite score built from the Compounder Score (business quality), Moat Score, Leadership Alignment and valuation vs peers.

Does HCP PLASTENE BULKPACK LIMITED have a competitive moat?

Stocky hasn't finalised a Moat Score for HCP PLASTENE BULKPACK LIMITED yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is HCP PLASTENE BULKPACK LIMITED's leadership aligned with shareholders?

Leadership Alignment for HCP PLASTENE BULKPACK LIMITED is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to HPBL.BO?

Resilience Profile for HCP PLASTENE BULKPACK LIMITED covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.

This is just the surface. See the whole picture on HCP PLASTENE BULKPACK LIMITED.

Sign up free and unlock the full analysis on HPBL.BO — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering HPBL.BO — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for HPBL.BO.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how HPBL.BO changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to HPBL.BO?" · "Is HPBL.BO overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

See HCP PLASTENE BULKPACK LIMITED the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in HPBL.BO would be worth today.
Practice portfolio
Buy HPBL.BO with virtual money and track it — zero risk.
Free · no real money · learn by doing Open HPBL.BO in Stocky →

Or jump straight to the interactive dashboard for HPBL.BO in the app.